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Abstract
The rat serotonin transporter (rSERT) is an N-glycosylated integral membrane protein with 12 transmembrane regions; the N-glycans
improve the ability of the SERT polypeptide chain to fold into a functional transporter, but they are not required for the transmembrane transport
of serotonin per se. In order to define the best system for the expression, purification and structural analysis of serotonin transporter (SERT), we
expressed SERT in Escherichia coli, Pichia pastoris, the baculovirus expression system and in four different stable mammalian cell lines. Two
stable cell lines that constitutively expressed SERT (Imi270 and Coca270) were constructed using episomal plasmids in HEK293 cells
expressing the EBNA-1 antigen. SERTexpression in the three different inducible stable mammalian cell lines was induced either by a decrease
in temperature (cell line pCytTS-SERT), the addition of tetracycline to the growth medium (cell line T-REx-SERT) or by adding DMSO which
caused the cells to differentiate (cell lineMEL-SERT). All themammalian cell lines expressed functional SERT, but SERTexpressed inE. coli or
P. pastoris was nonfunctional as assessed by 5-hydroxytryptamine uptake and inhibitor binding assays. Expression of functional SERT in the
mammalian cell lines was assessed by an inhibitor binding assay; the cell lines pCytTS-SERT, Imi270 and Coca270 contained levels of
functional SERT similar to that of the standard baculovirus expression system (250,000 copies per cell). The expression of SERT in induced T-
REx-SERTcells was 400,000 copies per cell, but inMEL-SERT it was only 80,000 copies per cell. All themammalian stable cell lines expressed
SERTat the plasma membrane as assessed by [3H]-5-hydroxytryptamine uptake into whole cells, but the Vmax for the T-Rex-SERTcell line was
10-fold higher than any of the other cell lines. It was noticeable that the cell lines that constitutively expressed SERT grew extremely poorly,
compared to the inducible cell lines whose growth rates were similar to the parental cell lines when not induced. In addition, the cell lines MEL-
SERT, Imi270 and T-REx-SERTall expressed fully N-glycosylated SERTand no unglycosylated inactive protein, in contrast to the baculovirus
expression system where the vast majority of expressed SERT was unglycosylated and nonfunctional.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
The initial problem that has to be addressed when
studying the structure and function of membrane proteins
is which heterologous protein expression system should
be used for the production of the membrane protein of
interest. Despite extensive experience from a wide variety
of expression systems and expressed proteins, it is not
easy to predict which system will be best for a given
mammalian membrane protein [1]. ‘Best’ in this context
could mean good cell surface expression, the presence of
functional protein or high levels of functional protein
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transporter; TBS, Tris-buffered saline
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production, or a combination of these. Published expres-
sion studies are often limited to only one or two
expression systems, which makes it very difficult to
draw meaningful conclusions about which is the best
expression system for a particular membrane protein. We
have decided to approach the expression problem by
choosing one particular membrane protein and studying
its expression in seven different systems. The membrane
protein we chose was the rat serotonin transporter
(rSERT) because it has a number of particular character-
istics that make it both a user-friendly and challenging
example of a mammalian membrane protein to be over-
expressed.
Serotonin transporter (SERT) is expressed at the plasma
membrane in many mammalian cell types including neu-
rons, platelets and placenta, where it transports serotonin
into the cell coupled to the inward movement of Cl and
Na+ down their concentration gradients [2,3]. There are
predicted to be 12 transmembrane regions in SERT with
the N- and C-terminus intracellular and a large extracel-
lular loop between transmembrane regions 3 and 4 that
contains two N-glycans. This model is supported by
topological studies using antibody labelling techniques
[4] and the binding of maleimides to SERT mutants with
single-reactive cysteines [5]. To study the function of the
N-glycans, a mutant SERT lacking both N-glycosylation
sites was constructed; unglycosylated SERT transported
[3H]-5HT and bound the inhibitor [125I]-RTI55 with iden-
tical kinetic parameters to native SERT, but functional
expression levels were 20-fold lower compared to glyco-
sylated SERT. This suggested that the N-glycans were not
essential for SERT activity per se, but that they improved
the folding and/or stability of SERT in the membrane [6].
The fact that the N-glycans on SERT are important in the
interaction of SERT with the molecular chaperone calnexin
lends further support to this hypothesis [7]. One character-
istic of SERT that makes it particularly suitable for
expression studies is that it binds antidepressant drugs
and cocaine analogues with very high affinity. Binding
assays can be performed on crude membrane preparations
from whole cells, allowing the accurate determination of
functional SERT molecules per cell, even if SERT is
sequestered in the endoplasmic reticulum and therefore
incapable of transporting serotonin into the intact cell [8].
Short epitope tags can also be placed at the C terminus
without impairing the expression levels or the function of
SERT [6,8,9]. Here we describe the production of SERT in
seven different expression systems with analysis by four
different criteria: (1) measurement of functional expression
levels by inhibitor binding assays; (2) measurement of cell
surface-expressed, functional SERT by serotonin uptake
assays; (3) determination of the major cellular compart-
ments containing expressed SERT by immunostaining of
whole cells and confocal microscopy; (4) determination of
the glycosylation status of the expressed SERT by Western
blotting.
2. Materials and methods
2.1. Expression and analysis of SERT in Escherichia coli
The coding region of the cDNA for rSERT [10] was
amplified by PCR using primers (5V–3V) TGAGAATTCG-
CAGCATGGAGACCACACCCTTAAATTC and
GCTGAATTCTTACACAGCATT (initiator Met under-
lined). All PCR products were verified by DNA sequenc-
ing. The 1913-bp product was digested with EcoRI and
the resulting 1901-bp fragment was ligated into EcoRI-
digested pTrcHisA (trc promoter, N-terminal hexahistidine
tag; Invitrogen), pRSETA (T7 promoter, N-terminal hex-
ahistidine tag; Invitrogen) and pGEX-KG (tac promoter,
N-terminal GST; modified form [11] of pGEX-2T from
Amersham Pharmacia). See Fig. 1 for a diagrammatic
representation of SERT fusions constructed. Expression
experiments were carried out using freshly transformed E.
coli BL21(DE3)pLysS, even when using the tac and trc
promoters, to allow direct comparison with expression
results using the T7 promoter. Cultures were grown in
2TY medium, either with osmotic stress (plus 1 M
sorbitol and 2.5 mM betaine [12]) or without, to A600 of
0.6–0.7 and expression was induced by addition of IPTG
to 1 mM. Following 1.5–2-h induction at 37 jC or room
temperature, cells were harvested, and membranes were
prepared as described in Ref. [13].
2.2. Expression and analysis of SERT in Pichia pastoris
EcoRI-digested PCR product (see E. colimethods above),
encompassing the rSERTcoding region and Kozak sequence,
was ligated into EcoRI-digested pHIL-D2 Pichia vector
(Invitrogen), to generate pHIL-D2-rSERT (Fig. 1). This
Fig. 1. Schematic diagram of SERT cDNAs expressed in each expression
system. Boxes (not to scale) represent open reading frames encoding the rat
serotonin transporter (rSERT) and various tags (His, hexa-histidine tag;
GST, glutathione S-transferase; TrxA, thioredoxin; H10F, deca-histidine tag
followed by a FLAG tag). The arrows represent the promoter used to
expressed SERT in each system. See Section 2 for further details.
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vector was linearised with NotI and used to transform P.
pastoris GS115 and SMD1168 as described previously [14].
SERTwas integrated into the alcohol oxidase (AOX) locus in
the Pichia genome, which resulted in the slow methanol
utilising (Muts) phenotype. Recombinant clones were
screened for their Muts phenotype by scoring growth on
minimal dextrose medium (MD, 1.34% (w/v) yeast nitrogen
base without amino acids, 4 10 5% (w/v) biotin, 2% (w/v)
glucose) and minimal methanol medium [MM, 1.34% (w/v)
yeast nitrogen base without amino acids, 4 10 5% (w/v)
biotin, 0.5% (v/v) methanol] at 30 jC for 48 h.
Expression of the SERTwas induced by transferring cells
grown in MD, to MM medium for 48 h at 30 jC, 300 rpm.
Crude membranes were then prepared as below. Cells were
harvested by centrifugation at 9000 g for 10 min at 4 jC
and were suspended in 50 mM TrisHCl pH 7.4, containing
120 mM NaCl, 5 mM KCl, 1 mM EDTA and protease
inhibitors (Completek, Roche). Cells were lysed by pas-
sage through a French Pressure cell at 20,000 p.s.i. and then
centrifuged at 10,000 g for 10 min at 4 jC to remove
unbroken cells. The supernatant was ultracentrifuged at
120,000 g for 2 h at 4 jC. The resulting membrane pellets
were suspended in the above buffer using an Ultra-Turrax
homogeniser and stored at  80 jC.
2.3. Expression of SERT using the baculovirus expression
system
Sf9 cells were grown and infected with a recombinant
baculovirus that expressed SERT with a FLAG tag at its C
terminus (bvSERT-TAG) exactly as previously described
[8].
2.4. Construction of a 293-EBNA stable cell line expressing
SERT from a constitutive promoter
In order to express an rSERT-TrxA-His10-FLAG fusion
protein (Fig. 1) in mammalian cells, a NotI/XbaI cassette
from plasmid pT43NTR-TrxA-H10F [15] containing the E.
coli thioredoxin gene (trxA) followed by DNA encoding an
in-frame His10 tag and a FLAG tag was ligated into NotI/
XbaI-digested plasmid pCGT125 [6], making plasmid
pCGT262. The EcoRV/XbaI cassette encoding rSERT-
TrxA-His10-FLAG in plasmid pCGT262 was subsequently
ligated into PvuII/NheI-digested plasmid pREP4 (Invitro-
gen) to make plasmid pCGT270. The presence of TrxA at
the C terminus of SERT was an attempt to improve the
purification properties of SERT (Tate, unpublished results).
293-EBNA (Invitrogen) is a cell line derived from
HEK293 cells that stably expresses the EBNA-1 antigen,
which is essential for the episomal replication of plasmids
such as pREP4 containing the EBV origin of replication,
oriP. Cells were grown as an adherent line in DMEM
supplemented with 10% FBS and 0.25 mg/ml geneticin at
37 jC in an atmosphere containing 5% CO2. Cells were
passaged every 2–3 days using standard tissue culture
techniques. Cultures of 293-EBNA cells were grown in
the absence or presence of the SERT inhibitors cocaine or
imipramine (1 Ag/ml in the media) for 1 week prior to
transfection; these three cell lines were each transfected with
plasmid pCGT270 by calcium phosphate precipitation. Two
days after transfection, the cells were split into medium
containing the selective antibiotic hygromycin (0.5 mg/ml).
One week later, single colonies could be seen in the flasks
containing inhibitors; the pools of cells were amplified
before aliquots were stored in liquid nitrogen or assayed
for the presence of SERT. Transfected cells grown in the
absence of inhibitors did not yield any hygromycin-resistant
colonies.
2.5. Inducible expression of SERT in mouse erythroleukae-
mic (MEL) cells
The rSERT cDNA was isolated as a SalI/NotI fragment
from plasmid pCGT109 (rSERT with no tag [6]) and ligated
downstream from the h-globin promoter into the SalI/NotI
sites of plasmid pEV3 [16] to make plasmid pCGT216 (Fig.
1). MEL cells were grown as a suspension culture in
DMEM containing 10% FCS and were grown in an atmos-
phere containing 5% CO2. Cells (2 107 cells in 0.8-ml
PBS) were electroporated with 50-Ag pCGT216 (960 AF,
0.2 kV) in a 4-mm cuvette. Cells were added to 150 ml of
complete medium and then split into 2-ml aliquots per well
of a 24-well plate. Selection for the plasmid started 24 h
after the transfection with 1 mg/ml G418. Ten clones were
produced and amplified. To induce the expression of SERT,
cells were split to 106 cells/ml in fresh medium and DMSO
was added to a final concentration of 2%. Cells were grown
for 4 days at 37 jC, harvested and resuspended in 1-ml PBS
with protease inhibitors (Completek, Roche) to about
2.5 104 cells/Al for analysis.
2.6. Tetracycline-inducible SERTexpression using the T-REx
system
The rSERT cDNA was transferred as an EcoRV/XbaI
fragment from plasmid pCGT262 (see above) to plasmid
pcDNA4/TO (Invitrogen) to make plasmid pCGT272 con-
taining rSERT expressed from the tetracycline-controlled
cytomegalovirus (CMV) promoter. The C-terminal TrxA-
His10-FLAG tag at the end of SERT was replaced with a
His10-FLAG tag by replacing the NotI/XbaI fragment with
oligonucleotides encoding the amino acid sequence AA-
AHHHHHHHHHHDYKDDDDKGG and a termination
codon. Plasmid pCGT273 expressing SERT-His10-FLAG
from the tetracycline-controlled CMV promoter (Fig. 1) was
used to transfect an HEK293 cell line (T-REx-293; Invitro-
gen) that expressed the tetracycline repressor protein TetR.
The T-REx-293 cell line was grown in DMEM contain-
ing 10% FCS and 5 Ag/ml blasticidin as an adherent cell
culture. The cells were transfected using Lipofectamine
2000 according to the manufacturer’s protocol (Life Tech-
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nologies) and split into 24-well plates. One day after trans-
fection, the selective antiobiotic Zeocin (Invitrogen) was
added to 200 Ag/ml to select for stable integrants. Clones
growing in individual wells were tested for SERT expres-
sion by induction with tetracycline (1 Ag/ml for 24 h),
harvesting the cells and performing a dot blot probed with
the anti-FLAG antiserum (see Western blotting below). The
most highly expressing clones as judged from the dot blot
were amplified and further characterized.
2.7. Cold-inducible expression of SERT using the pCytTS
system
To allow the transfer of the rSERT cDNA into plasmid
pCytTS, the EcoRV and XbaI restriction sites in plasmid
pCGT273 were converted respectively to a PacI site and
an AscI site. The oligonucleotide TTAATTAA was first
ligated into EcoRV-digested plasmid pCGT273 and then
the oligonucleotide CTAGGGCGCGCC was ligated into
the resultant plasmid digested with XbaI, to make plasmid
pCGT276. The PacI/AscI SERT insert from plasmid
pCGT276 was then ligated into PacI/AscI-digested plasmid
pCytTS [17] to make plasmid pCGT278 (Fig. 1).
The BHK-21 cell line was grown in DMEM supple-
mented with 10% FCS in an atmosphere containing 5%
CO2 as a suspension culture. The BHK-21 cells were
transfected with plasmid pCGT278 using Lipofectamine
2000 (Life Technologies) according to the manufacturer’s
protocol. The transfected cells were split into 24-well
plates with the antibiotic selection starting 1 day after
transfection (10 Ag/ml puromycin). Positive clones identi-
fied by induction and dot blotting (see below) were serially
diluted to ensure a homogeneous cell population and then
amplified. Cells were induced by placing a culture con-
taining about 0.5 106 cells/ml in an incubator at 29 or 33
jC for 3 days.
2.8. Inhibitor binding assays on crude membrane prepara-
tions
A pellet of mammalian cells (107 cells) was resuspended
in 1-ml PBS and transferred to a 1.5-ml microcentrifuge
tube. The cells were pelleted (30 s, 14,000 g) and resus-
pended in 0.1 PBS containing protease inhibitors (Com-
pletek, Roche). The cells were sheared by passaging seven
times through a 26-gauge needle and the crude membranes
were pelleted (10 min, 14,000 g, 4 jC). The crude
membranes were washed once with ice-cold PBS containing
protease inhibitors (Completek, Roche) and then resus-
pended in a final volume of 1 ml.
Single-point binding assays with the inhibitor [125I]-
RTI55 were performed exactly as previously described
[6,8]. Briefly, 50-Al reactions were set up in triplicate which
contained an aliquot of membranes, 2 nM [125I]-RTI55
(DuPont NEN) and in the absence or presence of 10 AM
cocaine to determine nonspecific binding. Membranes were
pelleted in a microcentrifuge (10 min, 14,000 g, 20 jC),
the supernatant carefully removed and the radioactivity
bound to the membranes determined on a gamma counter
(1261 MultiGamma, Wallac). The amount of membranes
added to the assay was sufficient to bind about 5% of the
total [125I]-RTI55 present.
2.9. [3H]-5HT transport assays
Mammalian cells were plated onto poly-L-lysine-coated
(0.1 mg/ml) 24-well plates. The 293-EBNA-Imi270 cell
line was grown for 3 days prior to uptake experiments in
medium that did not contain any imipramine. T-REx-
SERT cells were grown for 24 h and then induced by
the addition of 1.0 Ag/ml tetracycline; the cells were
grown for a further 16 h before uptake assays were
performed. The pCytTS-SERT cell line was grown at 37
jC for 24 h and then transferred to 29 jC for 48 h to
induce expression.
Just before the transport assay, the medium was aspirated
and the cells were washed with warm TB buffer (10 mM
Hepes pH 7.5, 150 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1
mM MgCl2). The assay volume was 0.4 ml which contained
105 cells. The assay was performed at room temperature and
was started by the addition of [3H]-5HT and terminated 3 or
6 min later by three washes of ice-cold TB containing 1 AM
paroxetine. Radioactivity was released from cells using 2%
SDS, which was then quantified by liquid scintillation
counting. Nonspecific uptake was defined as the uptake in
the presence of 10 AM paroxetine and this was subtracted
from the total to obtain the specific uptake. Data were
analysed using SigmaPlot 5.0 software package using the
Michaelis–Menten equation; kinetic parameters were deter-
mined by nonlinear regression.
2.10. Fixing and staining cells for immunofluorescence
analysis by confocal microscopy
Cells were grown on poly-L-lysine-coated coverslips in
24-well plates under standard culture conditions for each
particular cell line as described above. Generally cells were
seeded at about 20–50% confluency and allowed to grow
for 1–2 days before use, or before induction. Coverslips
were washed in 2-ml PBS in a 35-mm petri dish and then
incubated in ice-cold 2% paraformaldehyde in PBS at 4 jC
for 15 min. After aspiration, the remaining paraformalde-
hyde was quenched with 2-ml 50 mM NH4Ac/PBS for 10
min at room temperature. If cells were permeabilized,
nonspecific binding sites were blocked with 2-ml 10% goat
serum/0.1% NP40 in TBS for 15 min at room temperature.
The primary antibody was then added in 10% blocking
buffer and incubated for 1 h at room temperature. Anti-
FLAG m2 antibody (Sigma) was used at a dilution of
1:500. After washing three times for 5 min each in TBS/
0.02% NP40 (TBS: 20 mM Tris pH 7.6, 137 mM NaCl),
the secondary antibody Texas Red-conjugate (Molecular
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Probes) was added at 1:500 dilution in 1% goat serum/TBS
for 1 h at room temperature. The coverslips were then
washed three times for 5 min each in TBS/0.02% NP40,
rinsed briefly in water and blotted edge-on to tissue
immediately before mounting in 10-Al polyvinylalcohol
containing 2.5% DABCO. For specific staining of the
plasma membrane, a 0.01 mg/ml solution of concanavalin
A–FITC conjugate (Sigma) in PBS was added to the cells
before blocking and incubated at 4 jC for 1 h; after
washing in PBS, the cells were blocked and probed as
above. Cells were visualised using a BioRad MRC1024
confocal microscope.
2.11. Western blotting
Protein samples were solubilized in GSB (20 mM Tris
pH6.8, 1% SDS, 10% w/v glycerol, 10 mM 2-mercaptoe-
thanol, 0.1% bromophenol blue) and incubated at 37 jC for
30 min. The proteins were separated on a 9% polyacryla-
mide gel and transferred to nitrocellulose (ECL, Amersham
Biosciences) using standard techniques. Blots were probed
with antibodies and developed using the ECL system
(Amersham Biosciences). The anti-FLAG m2 monoclonal
antibody (Sigma) and the anti-SERT CT-2 antibody [9] were
used at a dilution of 1:1000. Treatment of membranes with
endoglycosidase H and peptide:N-glycosidase F was per-
formed at 37 jC for 1 h using the manufacturer’s conditions
(New England Biolabs).
3. Results
3.1. Expression of SERT in E. coli
Initial experiments under standard growth conditions
showed that SERT could be expressed in E. coli both as
GST-rSERT or HexaHis-rSERT fusion proteins, under the
control of trc, tac and T7 promoters. However, induction of
expression was found to be detrimental to cell growth, with
low overall levels of expressions (100–200 Ag/l of culture),
as assessed by Western blotting, with most of the expressed
protein found to be in the form of insoluble aggregates. In
addition, the fusion protein was very susceptible to in vivo
truncation, most likely due to proteolysis. Significant
improvements in SERT expression were obtained by
decreasing the induction temperature and by the modifica-
tion of the growth medium (Fig. 2a). Growing E. coli in the
presence of 1 M sorbitol with the inclusion of the osmo-
protectant betaine [12] markedly improved expression lev-
els, the level of proteolysis was significantly reduced, and
induction of expression was no longer detrimental to cell
growth. Full-length GST-rSERT and hexaHis-rSERT were
now found to be associated with the bacterial membranes
and expression levels obtained were 2–3 mg/l. The appa-
rent molecular weight of GST-rSERT (80 kDa) and hex-
aHis-rSERT (64 kDa) on SDS-PAGE represented the full-
length fusion protein despite the molecular weights being
95 and 75 kDa, respectively. The full-length nature of the
fusion proteins was determined by the reactivity of anti-
bodies that recognized the N-terminal tag and the C
terminus of SERT (results not shown). The 175-kDa band
Fig. 2. Western blots of the serotonin transporter expressed in E. coli and P.
pastoris. (a) The serotonin transporter was expressed in E. coli
BL21(DE3)pLysS, with an N-terminal hexahistidine tag (lanes 1–4) or
glutathione S-transferase tag (lanes 5–7), using plasmids pTrcHisA (trc
promoter; lanes 1 and 2), pRSETA (T7 promoter, lanes 3 and 4) or pGEX-
KG (tac promoter, lanes 5–7). Cells were grown to early log phase in
2TY medium with or without osmotic stress (1 M sorbitol and 2.5 mM
betaine); expression was induced (1 mM IPTG) at room temperature for 2
h. Membrane preparations from the cultures were Western blotted with anti-
serotonin transporter C-terminus antiserum (lanes 1–6), and also anti-GST
(lane 7). (b) Membranes were prepared from both uninduced (UI) and
induced (I) cultures of P. pastoris clone B119 (a derivative of strain
SMD1168) that contained SERT cDNA under the control of the AOX1
promoter. N-Glycans were removed by the treatment of membranes with
either endoglycosidase H ( +H) or with peptide:N-glycosidase F ( + F). The
unglycosylated (UG) and high-mannose core glycosylated (HM) forms of
SERT are indicated by arrows. Membrane preparations were probed with
anti-serotonin transporter C-terminus antiserum.
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represented an aggregated form of SERT also observed on
SDS-PAGE analysis of insect cell membranes containing
SERT produced using the baculovirus expression system
[6].
Binding of [3H]-imipramine and [3H]-paroxetine to E.
coli-expressed SERT was examined. In both cases, bind-
ing was found to be low affinity, with KD values of
approximately 1 AM (results not shown), compared to
nanomolar values for the native transporter. [3H]-Imipr-
amine binding to the bacterial membranes could be
displaced by a range of serotonin transporter ligands (at
10 AM) and, to a small extent, by serotonin (at 100 AM).
This shows that the affinity of the transporter for sero-
tonin and antidepressant drugs is lower than that of the
native protein, suggesting one or more incompletely
folded states.
3.2. Expression of SERT in P. pastoris
The rSERT cDNA was inserted into an expression
cassette under the control of the inducible alcohol oxidase
promoter. Following transformation of Pichia strains, the
integration of the expression cassette into the yeast genome
was confirmed by three methods: (1) selection screening of
the slow methanol-utilisation phenotype (Muts) of individ-
ual recombinants; (2) PCR of Pichia genomic DNA with
primers to the alcohol oxidase promoter; (3) Southern
blotting of individual clones. These tests identified 36
independent clones that contained one to six copies of
the SERT cDNA, 16 clones in strain GS115 and 20 clones
in strain SMD1168. The pep4 mutation in SMD1168
causes a deficiency in proteinase A activity, which is
required for the proteolytic activation of a number of
proteases in P. pastoris. SERT expression following meth-
anol induction was examined by Northern blotting, [3H]-
imipramine binding and Western blotting of cell membrane
preparations. A GS115 clone with the highest expression
levels, as judged by Western blotting and [3H]-imipramine
binding, was found to have six copies of the expression
cassette.
The Pichia-expressed SERT was found to be associ-
ated with cell membranes and, on Western blotting (Fig.
2b), was observed to migrate at 49, 58 and 65 kDa. The
49-kDa species represented full-length SERT. Treatment
of membranes with endoglycosidase H and PNGaseF
resulted in a decrease in the amount of the 65- and
58-kDa species but did not result in their complete
removal. This is consistent with the presence of N-
glycans on SERT that is misfolded, with consequently
poor accessibility of the N-glycans to the glycosidases.
The suggestion that expressed SERT was poorly or
incompletely folded was substantiated by the absence of
[3H]-5HT transport into the rSERT-expressing Pichia
clones. In addition, binding of [3H]-imipramine and
[3H]-paroxetine to membranes was found to be of low
affinity (KDf 1 AM, results not shown).
3.3. Construction of four different mammalian cell lines for
the production of SERT
Overexpression of integral membrane proteins often
results in impaired cell growth and can result in positive
selection against high expressing clones [1]. In an effort to
prevent this happening during the selection of stable cell
lines constitutively expressing potentially high levels of
SERT, specific SERT inhibitors were added to the cell
culture medium. The inclusion of either cocaine or imipr-
amine (1 Ag/ml) did not have any effect on the rate of
growth of the 293-EBNA cells. Transfection of cells grown
in the presence of either cocaine or imipramine led to the
generation of hygromycin-resistant cell lines named 293-
EBNA-Coca270 and 293-EBNA-Imi270, respectively. No
antibiotic resistant colonies were found in transfections of
cells grown in the absence of inhibitors. Both Imi270 and
Coca270 cells grew very poorly with a doubling time of
about 36 h. Characterisation of the cell lines is described in
the following section.
The cell lines Imi270 and Coca270 were both grown in
the presence of the SERT inhibitors imipramine and
cocaine, respectively. Therefore, the poor growth character-
istics of the Imi270 and Coca270 cell lines implied that it
was the presence of SERT protein itself, and not its activity,
that adversely affected cell growth. If this was the case, then
by using an inducible mammalian expression system, stable
cell lines would be developed in the absence of expressed
SERT, and good expression could be produced on induction.
Therefore, three different inducible systems were tested for
the overexpression of SERT. The characteristics of each
expression system are briefly outlined below.
(1) The MEL cell system [16] uses the ability of MEL
cells to differentiate in the presence of DMSO to more
erythroid-type cells; a consequence of this is the production
of haemoglobin, which is under tight developmental control.
Placing SERT cDNA under the control of the h-globin
promoter allows the expression of the protein on addition
of DMSO.
(2) The pCytTS system [17] uses temperature as the
inducing agent. The system relies on a temperature-sensi-
tive, non-cytopathic Sindbis virus replicase as the core
component. A stable cell line is constructed that constitu-
tively expresses the replicase and SERT in tandem on the
same mRNA, which will result initially in the production of
the replicase but not of SERT. At 37 jC the replicase is
inactive, but if the temperature falls to 29–35 jC the
replicase becomes active and produces minus strand replicas
of the replicase-SERT mRNA; subsequently, SERT-encod-
ing mRNA is produced from this template using the sub-
genomic Sindbis virus promoter upstream from SERT. The
result is a massive production of SERT mRNA.
(3) The T-REx expression system (Invitrogen) is con-
trolled using the bacterial control elements for expression of
the tetracycline transporter. The repressor protein TetR
prevents expression of the transporter in the absence of
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tetracycline by binding to a specific DNA sequence, the Tet
operator site (TetO), in the promoter region and thus
prevents transcription. In the presence of tetracycline, the
repressor protein is inactivated by tetracycline binding, thus
releasing the blockage at the operator site, and hence tran-
scription can proceed. In the T-REx system, cell lines stably
producing the repressor protein TetR are stably transfected
with DNA encoding SERT under the control of a CMV
promoter, but which also contains two tandem TetO sites
between the promoter and the SERT cDNA. SERT expres-
sion could be induced by the addition of tetracycline to the
culture medium.
Stable cell lines for each of the three inducible expression
systems were constructed as described in Section 2. The
three cell lines were called MEL-SERT216, pCytTS-BHK-
SERT278 and T-REx-293-SERT273, which for the sake of
brevity will be referred to as MEL-SERT, pCytTS-SERT
and T-REx-SERT, respectively (Fig. 1). It was noticeable
that the inducible SERT-expressing cell lines grew at the
same rate as untransfected cells, in contrast to the poor
growth of the Coca270 and Imi270 cell lines that expressed
SERT constitutively.
3.4. Comparison of SERT production in four mammalian
cell lines
SERT production in the cell lines Imi270, MEL-SERT,
pCytTS-SERT and T-REx-SERT was assessed using West-
ern blotting, inhibitor binding assays on crude membranes,
[3H]-serotonin uptake into whole cells and confocal micro-
scopy of immunostained cells. For each of the individual
inducible cell lines, a time course of expression was
performed to determine the optimum time for harvesting
(results not shown). Consequently, the MEL-SERT cell line
was induced for 4 days, the pCytTS-SERT cell line was
induced for 3 days and the T-REx-SERT cell line was
induced for 24 h.
Western blots of whole-cell extracts (Fig. 3) showed that
SERT was expressed in all four cell lines. The mobility of
the SERT-immunoreactive band varied between the expres-
sion systems and was due to different N-glycosylated states
of the transporter; unglycosylated SERT has an apparent Mr
of about 55 kDa on SDS-PAGE, except in the Imi270 cell
line which expresses a SERT-TrxA fusion with apparent Mr
of 70 kDa (Fig. 1). The apparent Mr of 55 kDa is consistent
with the expression of full-length SERT [6] despite SERT
having a calculated weight of 69 kDa. A comparison of the
mobilities after treatment with endoglycosidase H (endoH),
which removes high-mannose core N-glycans, and with
peptide:N-glycosidase F (PNGase F), which removes all
types of N-glycans, defined the glycosylation status of each
species. The apparent mobility shifts on SDS-PAGE due to
the N-glycans in each cell line are listed at the end of the
results section in Table 2. SERT produced in the cell line
pCytTS-SERT was a mixture of mainly unglycosylated and
high-mannose core N-glycosylated protein, with no detect-
able complex N-glycosylation. This is very similar to SERT
expressed in Pichia (Fig. 2b), although the yeast N-glycans
were slightly larger than high-mannose N-glycans in mam-
malian cells, and in SERT produced using the baculovirus
expression system. In contrast, the major SERT species in
the cell lines MEL-SERT, Imi270 and T-REx-SERT was the
complex N-glycosylated species with no detectable ungly-
cosylated SERT. In addition, both T-REx-SERT and Imi270
cell lines contained SERT with some high-mannose core N-
glycans.
The different types of N-glycosylation are indicators of
the subcellular localisation of SERT. Unglycosylated SERT
is predominantly nonfunctional and was found mainly in the
ER where it was synthesized. Addition of the high-mannose
core N-glycan is a co-translational event and only minor
trimming of the oligosaccharide occurs in the ER (reviewed
in Ref. [18]). Further trimming and elongation of the N-
glycans occurs in the Golgi apparatus prior to transport of
SERT to the cell surface. Thus, the high-mannose form is
likely to be intracellular and the complex form is mainly
Fig. 3. N-Glycosylation of the serotonin transporter expressed in four
mammalian cell lines. Crude membranes were prepared from uninduced
(UI) and induced (I) cell lines and separated on 9% SDS-polyacrylamide
gels which were subsequently transferred to nitrocellulose and probed with
either anti-SERT CT-2 (a) or with an anti-FLAG antiserum (b, c, d). N-
Glycosylation was removed from SERT by the treatment of membranes
with either endoglycosidase H ( +H) or with peptide:N-glycosidase F ( + F).
The different glycosylated forms of SERT are indicated: UG, unglycosy-
lated; HM, high-mannose core N-glycans; C, complex N-glycans. The
different tags on the expressed SERT are indicated in parentheses (see also
Section 2).
C.G. Tate et al. / Biochimica et Biophysica Acta 1610 (2003) 141–153 147
expressed at or near the plasma membrane. Confocal micro-
scopy of cells stained for SERT using anti-FLAG antibodies
(Fig. 4) confirmed the Western blotting results. The cell
surface was labelled with FITC-conjugated concanavalin A
and this co-localized with SERT in the Imi270 and T-REx-
SERT cell lines. In contrast, the pCytTS-SERT cell line
produced SERT that was mainly in internal membranes,
which is identical for SERT expressed using the baculovirus
expression system. The confocal microscopy also high-
lighted one of the major differences between SERT expres-
sions in the T-REx-SERT and the Imi270 cell lines; only
about 30% of the cells in the Imi270 cell line expressed
SERT, in contrast to the T-REx cell line where at least 95%
of cells expressed SERT. Efforts to improve the Imi270 cell
line by cloning single cells after serial dilution were unsuc-
cessful.
Uptake of [3H]-5HT into whole cells showed that the cell
surface-expressed SERT in the Imi270 and T-REx-SERT
cell lines was fully functional (Fig. 5). However, there were
marked differences in the levels of cell surface expression;
Imi270 cells had a Vmax of 28.1F1.5 pmol/min/10
6 cells in
comparison to induced T-REx-SERT cells that had a Vmax of
212F 29 pmol/min/106 cells (Table 1). One parameter that
changed markedly in the Imi270 and T-REx-SERT cell lines
was the Km for 5HT uptake, which varied between 204 nM
in uninduced T-REx-SERT and 1854 nM in Imi270. This
difference correlated with expression levels so that low
copies of SERT per cell gave a low Km (high affinity) and
high copies per cell gave a high Km (low affinity); note that
the number of SERT copies per individual cell in Imi270 is
actually higher than in induced T-REx-SERT (see below).
This variation in Km has been observed in the Xenopus
oocyte expression system and was attributed to the lack of a
SERT modulator on overexpression that is essential for
high-affinity 5HT transport [19]. The MEL-SERT cell line
also showed specific [3H]-5HT uptake but this was not
characterised further due to the overall very low SERT
expression levels (Table 2). The pCytTS-SERT cell line
showed specific [3H]-5HT uptake in the uninduced state
(Vmax 1.62F 0.07 pmol/min/10
6 cells), which was double
Fig. 4. Confocal microscopy of immunostained cells expressing the serotonin transporter. SERT was expressed in four different cell lines. The baculovirus
expression system was used to express SERT in insect cells and the induction of SERT expression in the pCytTS-SERT and T-REx-SERT cell lines was
performed as described in Section 2. These expression systems were compared to constitutive expression in the Imi270 cell line. Three different fields of view
are given for each cell line (column of three panels). Staining was performed with the anti-FLAG antibody and an anti-mouse antibody conjugated with Texas
Red on permeabilized cells to stain SERT (1st row). The cell surface was defined using FITC-conjugated concanavalin A, which was used to stain
unpermeabilized cells (second row). Double labelling of the cells with both FITC-concanavalin A and anti-FLAG is shown in the third row (the Imi270 cell line
was permeabilized during the concanavalin A treatment). The scale bar represents 10 Am.
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that seen in the parental BHK cells (Vmax 0.89F 0.01 pmol/
min/106 cells). Induction of the pCytTS-cells at 33 jC
resulted in a small increase (Fig 5b) in the level of func-
tional cell surface expressed SERT (Vmax 4.77F 1.55 pmol/
min/106 cells). However, [3H]-5HT uptake activity in the
pCytTS-SERT cell line decreased if cold induction was
performed at 29 jC, as did the expression of the endogenous
SERT transporter in the parental BHK cell line (Table 1).
The very low levels of [3H]-5HT uptake in the pCytTS-
SERT cell line were consistent with the apparent absence of
complex N-glycans on SERT seen in the Western blots (Fig.
Fig. 5. Uptake of [3H]-5HT into whole cells. Cell lines were grown and
saturation kinetic experiments were performed as described in Section 2. (a)
Imi270 cell line with constitutive expression of SERT. (b) The pCytTS-
SERT cell line was either uninduced (filled circles) or induced at 33 jC for
48 h (open circles). (c) The T-REx-SERT cell line was either uninduced
(filled circles) or induced with 1 Ag/ml tetracycline for 24 h (open circles).
Each data point was determined in triplicate and was plotted as mean
valueF S.E. The saturation curve presented is a representative of three
independent experiments, each giving similar results.
Table 1
Summary of [3H]-5HT uptake data for different mammalian cell lines
Cell line Vmax [pmol/min/10
6 cells]a Km [nM]
a
Imi 270 28.1F1.5 1786.4F 173.2
CytTS-SERT uninduced 1.62F 0.07 232F 58
induced (48 h, 29 jC) 5.8F 1.1 159F 35
induced (48 h, 33 jC) 4.8F 1.6 192F 41
BHK cells untreated 0.89F 0.01 255F 10
48 h, 29 jC 0.45F 0.02 254F 39
T-REx-SERT uninduced 12.8F 2.2 204F 69
induced (10 ng/ml tet) 82.2F 6.7 1300F 100
induced (1 Ag/ml tet) 212.3F 29.0 1610F 495
a 5-HT uptake assays were performed as described in Section 2. Data
were fitted to the Michaelis –Menten equation using the nonlinear
regression analysis tool of SigmaPlot. Vmax and Km values given are the
meanF S.E. of two to four independent experiments.
Table 2
A comparison of expression systems used for the production of SERT
Expression
system
Typea Cell
line
Nonfunctional
expression
levels
(mg/l)b
Functional
expression
levels
(copies/cell)c
Mass of
N-glycans
(kDa)
Escherichia coli I BL21
(DE3)
2–3 0 0
Pichia pastoris I GS115,
SMD1168
2–3 0 9, 16
Baculovirus:
SERT
I Sf9,
Sf21
f 0.5 250,000 6
Hi5,
MG1
f 1 250,000 6
Baculo:
SERT
+ calnexin
I Sf9 f 0.5 750,000 6
EBNA-293 C HEK293 minimal 280,000
(imi)
25, 4
minimal 290,000
(coca)
MEL-SERT UI MEL – 1000 18
I minimal 80,000
pCytTS-SERT UI BHK – 12,500 6
I present 240,000
T-REx-SERT UI HEK293 – 12,500 33, 6
I minimal 400,000
a I, induced; UI, uninduced; C, constitutive.
b Estimated from band intensities on a Western blot. ‘‘Minimal’’ implies
that all the expressed SERT is thought to be functional, but the presence of
misfolded SERT cannot be definitely ruled out.
c Determined from binding assays using the inhibitor [125I]-RTI55.
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3) and the lack of SERT immunostaining at the cell surface
(Fig. 4).
For the purification of SERT, the most important param-
eter is how much functional SERT is expressed per cell.
This was determined by single-point inhibitor binding
assays on crude membrane preparations from whole cells,
so that all functional molecules of SERT, regardless of their
cellular location, were assayed. Binding assays were per-
formed using the radiolabelled inhibitor [125I]-RTI55 and
showed (Table 2) that the T-REx-SERT cell line expressed
the most functional copies of SERT (400,000 copies per
cell). However, the confocal microscopy suggested that only
30% of the Imi270 cells expressed SERT, so therefore the
SERT-expressing cells could contain up to a million copies
of SERT per cell. The pCytTS-SERT cell line expressed
similar levels of SERT to the baculovirus expression system
(250,000 copies per cell).
3.5. Stability and inducibility of the cell lines
The stability of the inducible cell lines was considerably
improved in comparison to the constitutive 293-EBNA cell
lines Imi270 and Coca270, with no apparent increase in
their doubling time after transfection. The T-REx-SERT cell
line has been passaged continually for 3 months (30
passages) without any apparent reduction in the level of
cell surface expression (Fig. 6). In contrast, the Imi270 cell
line showed decreased expression on continuous passaging,
especially if imipramine was removed from the medium
(Fig. 6).
The inducibility of the various cell lines is apparent from
the Western blots and activity data. The T-REx-SERT cell
line expressed 12,500 copies per cell of SERT in the
uninduced state (Table 2) and a trace of SERT can be seen
on the Western blot (Fig. 3). One important observation was
that the amount of tetracycline required for the induction of
measurable SERT expression in the T-REx-SERT cell line
was extremely low (10 ng/ml), which justified the use of
bovine calf serum that was certified free of tetracycline to
ensure reproducible results (Fig. 7). No SERT was apparent
in the uninduced MEL-SERT cell line either from binding
Fig. 6. Stability of [3H]-5HT uptake activity in imipramine-deprived Imi270
and the T-REx-SERT cell lines over time. (a) Saturation kinetic experiments
were perfomed on Imi270 cells grown in the absence of imipramine for 3
days (filled triangles), 12 days (filled circles) or 21 days (open circles); Vmax
values for the data are, respectively, 29.5F 1.3, 21.5F 0.7 and 8.6F 0.7
pmol/min/106 cells. Each data point was determined in triplicate and was
plotted as mean valueF S.E. The saturation curve presented is a
representative of two independent experiments, each giving similar results.
(b) T-REx-SERT cells were passage two to three times a week as described
in Section 2. For uptake assays, cells were seeded down into 24-well plates
at the indicated passage number. Twenty-four hours later, SERT expression
was induced with 1 Ag/ml tetracycline. The uptake assay used a single
concentration of [3H]-5HT (5 AM) and was performed 20 h following
induction as described under Section 2. Data presented are the meanF S.E.
of one experiment at each time point performed in triplicate.
Fig. 7. Tetracycline-dependent induction of [3H]-5HT uptake. T-REx-SERT
cells were split into 24-well plates and 24 h later SERT expression was
induced with the indicated concentration of tetracycline. An uptake assay
using a single concentration of [3H]-5HT (5 AM) was performed 20 h
following induction as described under Section 2. Data presented are the
meanF S.E. of two independent experiments, each performed in triplicate.
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data (Table 2) or Western blots (Fig. 3). The pCytTS-SERT
cell line expressed low levels of functional SERT when
uninduced (Table 2), which was only evident on Western
blots after prolonged exposure (results not shown).
3.6. Are all the expressed SERT functional?
Crystallisation in either two or three dimensions requires
milligrams of highly purified protein that is all in a single,
functional conformation. It is, therefore, important to con-
sider whether the heterologous expression system used to
produce the protein is generating inactive protein in addition
to the functional material. In the case of the baculovirus
expression system it is clear that over 95% of expressed
SERT is unglycosylated and mainly nonfunctional and, in
addition, probably about 90% of the glycosylated SERT
produced is also nonfunctional. The best way to get a feel
for whether inactive SERT could be present is to use
Western blotting of membrane samples containing the
identical amount of functional SERT (Fig. 8). It is clear
that the baculovirus system expressed considerably more
SERT protein than the mammalian expression systems and,
because the lanes contain identical amounts of functional
SERT, this extra protein must be inactive. The high molec-
ular weight SERT produced by the baculovirus was SDS-
resistant aggregates and was not due to different glycosy-
lated states [6]. The differences in blotting signal between
the different mammalian cell lines were less pronounced
when compared to the baculovirus system. Both the Imi270
and T-REx-SERT cell lines gave Western blot signals of
similar intensity, suggesting that, for the same amount of
functional SERT, they express the same amount of SERT
polypeptide; this is indicative of fully functional SERT
expressed in both cell lines. In comparison, the pCytTS-
SERT cell line contained more SERT immunoreactive
material in relation to functional SERT, suggesting that a
proportion of SERT is misfolded and inactive. Careful
optimisation of the induction temperature of the pCyt-TS
cell line would inevitably reduce the amount of misfolded
SERT, but unglycosylated SERT was still apparent after
induction at 32 jC (results not shown).
4. Discussion
The most widely used expression systems for the pro-
duction of integral membrane proteins are undoubtedly E.
coli and the baculovirus expression system, and they have
both been used successfully to overexpress a wide variety of
transporters, receptors and channels [1]. P. pastoris has also
been successfully used, for example, for the production of G
protein-coupled receptors [20]. However, all these systems
have their limitations for the expression of mammalian
membrane proteins, especially if posttranslational modifica-
tions are required for the correct folding of a membrane
protein into its fully functional state. The direct comparison
of expressions of a particular membrane protein in many
different expression systems has not been frequently per-
formed, but the work described here will enable us to
choose the best system for producing SERT for purification
and crystallisation.
Heterologous expression of proteins in E. coli and yeast
has two great advantages over the mammalian expression
systems discussed here, namely the speed of producing
overexpressing strains and the ease and cheapness of large-
scale production. Expression of SERT in E. coli and Pichia
was a real possibility when this work was performed because
it had been shown that unglycosylated SERT was fully
functional for both 5HT uptake and inhibitor binding [6].
However, both systems failed to produce functional SERT as
assessed by uptake and binding experiments. This is
undoubtedly due to the recent observation [21,22] that SERT
has an obligatory requirement for cholesterol that cannot be
mimicked by other sterols, such as ergosterol, that are found
in yeasts. E. coli does not have any sterols in its membrane. It
may be possible to manipulate the sterol composition of the
SERT-expressing Pichia cell lines to contain cholesterol as
has been performed for Saccharomyces cerevisiae [23], but
in these experiments it is not clear whether the cholesterol
can reach the ER where membrane protein synthesis occurs.
In the absence of microbial expression systems that synthe-
size cholesterol in the ER, SERTwill have to be produced in
either insect or mammalian cells.
Prior to the work presented here, the best system for the
production of reasonable quantities of SERT was the bacu-
lovirus expression system (Table 2). However, although the
levels of expression were sufficient for purification, the
major proportion of misfolded SERT produced in the
baculovirus expression system probably contributed to the
poor specific activity of the purified SERT [24]. The best
Fig. 8. Levels of inactive SERT in the stable mammalian cell lines
compared to the baculovirus expression system. Whole-cell extracts
containing equivalent amounts of functional SERT were loaded per lane,
separated by SDS-PAGE and Western blotted. Lane 1, SERT expressed in
Hi5 cells using the baculovirus expression system; lane 2, induced CytTS-
SERT cells; lane 3, induced T-REx-SERT cells; lane 4, Imi270 cells.
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system for producing SERT in the stable mammalian cell
lines generated here is undoubtedly the tetracycline indu-
cible cell line T-REx-SERT. The level of functional expres-
sion was higher than using the standard baculovirus
expression system, but not quite as high as baculovirus-
mediated expression of SERT improved by the co-expres-
sion of the molecular chaperone calnexin (Table 2). How-
ever, the T-REx-SERT cell line has significant advantages
over the production of SERT from recombinant baculovi-
ruses. All the SERT expressed in the T-REx-SERT cell line
are N-glycosylated, and probably the majority of them are
functional as these are expressed at the cell surface. The T-
REx-SERT cell line offers the opportunity to purify SERT
that is probably all fully functional before the start of
purification. Another advantage of the T-REx-SERT cell
line is the high level of cell surface-expressed SERT, which
is about 10 times higher than that obtained with previously
published cell lines [25,26] and transient transfections [27];
this may facilitate future analyses of protein–protein and
lipid–protein interactions of SERT in the plasma membrane.
The only other case that we are aware of where a transporter
(the human anion exchanger, band 3) was also expressed in
an inducible mammalian system also led to stable, high
expression levels of nearly 900,000 functional copies per
cell [28]. However, these levels of expression would require
large-scale growth of the cell lines; a 10-l culture of T-REx-
SERT cells would yield about 1 mg of SERT before
purification, assuming a cell density of 2 106 cells/ml.
The other two inducible cell lines characterised, MEL-
SERT and pCytTS-SERT, were not as successful as the T-
REx-SERT cell line, but probably for different reasons. The
MEL-SERT cell line had very low levels of expression,
perhaps due to the weakness of the h-globin promoter, but
the expressed SERTwas all fully N-glycosylated. In contrast,
the pCytTS expression system is designed to produce a large
amount of mRNA, just as with a viral infection, and this may
have been the cause of the production of unglycosylated,
nonfunctional SERT, just as in the baculovirus expression
system. However, increasing the induction temperature from
29 to 33 jC to decrease the activity of the replicase, and hence
reduce the intracellular mRNA levels, did not abolish the
production of unglycosylated SERT (results not shown).
Another possible reason for the production of unglycosylated
SERT in the induced pCytTS-SERT cell line was that SERT
folding could be less efficient at 29 jC than at 37 jC. This
was suggested by the decrease in cell surface expression in
induced pCytTS-SERTcells and in the parental BHK cells. It
seemed unlikely that there was a global effect on protein
expression in BHK cells at 29–33 jC, because this system
has been very successful in producing large quantities of
secreted proteins [17]. The pCytTS-SERT cell line does have
advantages over the baculovirus expression system; the BHK
cell line is very easy to grow in suspension to high cell
densities and to induce during fermentation compared to the
baculovirus system with its requirement of high-titre viruses.
In addition, there is considerably less misfolded SERT
expressed in the pCytTS-SERT cell line than in the baculo-
virus system. It is likely that the pCytTS system will prove
successful for the expression of many receptors and ion
channels that are not dependent on posttranslational modifi-
cations for efficient folding.
The comparison of four different mammalian expression
systems may not be ideal because different parental cell
lines were used in their construction. It is clear that the level
of cell surface expression of a membrane protein may
sometimes be dictated by the cell in which it is expressed
[1], although the fact that SERT is found in various tissues
(brain, placenta, platelets) may make this seem unlikely.
However, the proteins required for the insertion of SERT
into the ER in a functional form would be expected to be
fully conserved between the mouse, human and hamster cell
lines used in this study. Therefore, the levels of functional
SERT expression per cell are probably dictated mainly by
translational effects. A fuller understanding of how SERT
expression is affected by cell type will require the use of
different expression systems, such as the Semliki Forest
Virus system.
5. Conclusion
This study showed that stable inducible mammalian cell
lines produced levels of functional SERT similar to that of
the baculovirus expression system. In addition, the majority
of the expressed SERT was functional, whereas in the
baculovirus expression system, the vast majority was non-
functional. The levels of expression in the T-REx-SERT cell
line are still not high enough to avoid the need for large-
scale fermentation for the routine production of milligram
quantities of functional SERT for crystallisation.
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